Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
OVID Ovid Therapeutics
- 0.644
- -0.002-0.29%
Close Feb 14 16:00 ET
- 0.657
- +0.013+2.05%
Post 20:01 ET
45.72MMarket Cap-1.40P/E (TTM)
0.660High0.632Low280.65KVolume0.650Open0.646Pre Close181.55KTurnover0.60%Turnover RatioLossP/E (Static)71.01MShares3.79152wk High0.60P/B29.91MFloat Cap0.57152wk Low--Dividend TTM46.45MShs Float15.929Historical High--Div YieldTTM4.34%Amplitude0.571Historical Low0.646Avg Price1Lot Size
About Ovid Therapeutics Company
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
Company Profile
SymbolOVID
Company NameOvid Therapeutics
Listing DateMay 5, 2017
Issue Price15.00
Founded2014
CEOMr. Jeremy M. Levin, D.Phil.,M.B.
MarketNASDAQ
Employees40
Fiscal Year Ends12-31
Address441 9th Avenue,14th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10001
Phone1-646-661-7661
Websitehttp://www.ovidrx.com
Company Executives
- Name
- Position
- Salary
- Jeremy M. Levin, D.Phil.,M.B.
- Chairman of the Board and Chief Executive Officer
- 2.14M
- Jeffrey A. Rona
- Principal Accounting Officer, Chief Business Officer and Chief Financial Officer
- 1.08M
- Margaret Alexander
- Chief Operating Officer and President
- --
- Barbara G. Duncan
- Independent Director
- 86.66K
- Bart Friedman, J.D.
- Lead Independent Director
- 104.16K
- Dr. Karen Bernstein, PhD
- Independent Director
- 91.66K
- Dr. Robert Michael Poole, F.A.C.P.,M.D.
- Independent Director
- 79.16K
- Dr. Kevin Fitzgerald, PhD
- Independent Director
- 71.66K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.